Although it's not always easy to determine if an individual can make decisions, a judge understands the obvious that a ...

ALZpath’s pTau217 antibody was released in 2023 and continues to be a key focus in Alzheimer’s disease research and ...

The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25 ...

Alzheimer’s disease could soon be a distant memory. A revolutionary new Alzheimer’s drug named lecanemab could mark a major breakthrough in the decades-long battle against the neurological ...

Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...

Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of Alzheimer's and all other ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

Researchers say the repurposed drugs could accelerate a long-stalled path toward meaningful Alzheimer’s treatment. (Scripps ...

Scientists at UCSF have uncovered how certain immune cells in the brain, called microglia, can effectively digest toxic ...

The Alzheimer's Association® will present 10 scientific awards at the Alzheimer's Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy ...

The Alzheimer’s Association Walk to End Alzheimer’s will take place at Burlington Athletic Stadium, 1450 Graham St., in ...

Trontinemab's Phase Ib/IIa Brainshuttle AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative and ARIA-E remaining Design of the Phase III TR ...